Lindbrook Capital’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $8.83K | Buy |
1,670
+714
| +75% | +$3.78K | ﹤0.01% | 1708 |
|
|
2024
Q4 | $6.46K | Buy |
956
+246
| +35% | +$1.66K | ﹤0.01% | 1872 |
|
|
2024
Q3 | $4.68K | Buy |
710
+73
| +11% | +$481 | ﹤0.01% | 2039 |
|
|
2024
Q2 | $4.78K | Buy |
637
+392
| +160% | +$2.94K | ﹤0.01% | 2017 |
|
|
2024
Q1 | $2.44K | Hold |
245
| – | – | ﹤0.01% | 2170 |
|
|
2023
Q4 | $2.42K | Sell |
245
-207
| -46% | -$2.04K | ﹤0.01% | 2203 |
|
|
2023
Q3 | $3.46K | Buy |
452
+207
| +84% | +$1.58K | ﹤0.01% | 1930 |
|
|
2023
Q2 | $1.83K | Buy |
+245
| New | +$1.83K | ﹤0.01% | 2179 |
|
|
2022
Q4 | – | Sell |
-122
| Closed | -$1K | – | 3005 |
|
|
2022
Q3 | $1K | Buy |
+122
| New | +$1K | ﹤0.01% | 2470 |
|